1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Squamous Non-Small Cell Lung Carcinoma Global Clinical Trials Review, H1, 2014

Squamous Non-Small Cell Lung Carcinoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Squamous Non-Small Cell Lung Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Squamous Non-Small Cell Lung Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Squamous Non-Small Cell Lung Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Squamous Non-Small Cell Lung Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Squamous Non-Small Cell Lung Carcinoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Squamous Non-Small Cell Lung Carcinoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Squamous Non-Small Cell Lung Carcinoma to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Squamous Non-Small Cell Lung Carcinoma to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Squamous Non-Small Cell Lung Carcinoma 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Sun Farm Corporation 28
Clinical Trial Overview of Sun Farm Corporation 28
SCRI Development Innovations, LLC 29
Clinical Trial Overview of SCRI Development Innovations, LLC 29
Pfizer Inc. 30
Clinical Trial Overview of Pfizer Inc. 30
Eli Lilly and Company 31
Clinical Trial Overview of Eli Lilly and Company 31
C. H. Boehringer Sohn AG and Co. KG 32
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 32
Bayer AG 33
Clinical Trial Overview of Bayer AG 33
Amgen Inc. 34
Clinical Trial Overview of Amgen Inc. 34
Clinical Trial Overview of Top Institutes / Government 35
Seoul Veterans Hospital 35
Clinical Trial Overview of Seoul Veterans Hospital 35
Washington Hospital Center 36
Clinical Trial Overview of Washington Hospital Center 36
Ottawa Hospital Research Institute 37
Clinical Trial Overview of Ottawa Hospital Research Institute 37
Sarah Cannon Research Institute 38
Clinical Trial Overview of Sarah Cannon Research Institute 38
UCLA's Jonsson Comprehensive Cancer Center 39
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 39
North Central Cancer Treatment Group 40
Clinical Trial Overview of North Central Cancer Treatment Group 40
National Cancer Institute 41
Clinical Trial Overview of National Cancer Institute 41
The University of Texas M. D. Anderson Cancer Center 42
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 42
Five Key Clinical Profiles 43
Appendix 147
Abbreviations 147
Definitions 147
Research Methodology 148
Secondary Research 148
About GlobalData 149
Contact Us 149
Disclaimer 149
Source 150

List of Tables
Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials by Region, 2014* 7
Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Squamous Non-Small Cell Lung Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Squamous Non-Small Cell Lung Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Squamous Non-Small Cell Lung Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Squamous Non-Small Cell Lung Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Squamous Non-Small Cell Lung Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Suspended Clinical Trials, 2014* 22
Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Squamous Non-Small Cell Lung Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Farm Corporation, 2014* 28
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by SCRI Development Innovations, LLC, 2014* 29
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 30
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 31
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2014* 32
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 33
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 34
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul Veterans Hospital, 2014* 35
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington Hospital Center, 2014* 36
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2014* 37
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2014* 38
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2014* 39
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2014* 40
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 41
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 42

List of Figures
Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 13
Proportion of Squamous Non-Small Cell Lung Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Squamous Non-Small Cell Lung Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Squamous Non-Small Cell Lung Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Squamous Non-Small Cell Lung Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Squamous Non-Small Cell Lung Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Squamous Non-Small Cell Lung Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 148

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Market Access Impact: Non-Small Cell Lung Cancer (EU5) 2016

Market Access Impact: Non-Small Cell Lung Cancer (EU5) 2016

  • $ 5390
  • Industry report
  • September 2016
  • by Firstword Pharma

Prescription barriers hurt 5 of the 9 brands we surveyed. Is your brand losing market share? In the EU5, one of the most prescribed NSCLC drugs is stuck in 2nd place due to the biggest barrier-related ...

Market Access Impact: Non-Small Cell Lung Cancer (US) 2016

Market Access Impact: Non-Small Cell Lung Cancer (US) 2016

  • $ 5390
  • Industry report
  • September 2016
  • by Firstword Pharma

7 of the 10 brands we surveyed lose share due to market barriers. Is your brand one of them? In the US, market barriers are causing 7 of the 10 NSCLC drugs we surveyed to lose market share. What’s ...


Download Unlimited Documents from Trusted Public Sources

Digestive System Disorder and Endocrine Disease Statistics in the US

  • December 2016
    4 pages
  • Digestive Syste...  

    Endocrine Disea...  

  • United States  

View report >

Cancer Statistics in the UK

  • December 2016
    20 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

Cancer Statistics in the US

  • December 2016
    112 pages
  • Cancer  

  • United States  

    North America  

View report >

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.